Diamyd Medical AB (publ) (DMYD-B) — Working Capital to Net Assets Ratio
Diamyd Medical AB (publ) (DMYD-B) has a Working Capital to Net Assets ratio of 92.2% as of February 2026. Working capital of Skr156.52 Million (current assets of Skr197.44 Million minus current liabilities of Skr40.92 Million) is measured against net assets of Skr169.79 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Diamyd Medical AB (publ) to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Diamyd Medical AB (publ) Working Capital to Net Assets (2010–2025)
This chart shows how Diamyd Medical AB (publ)'s Working Capital to Net Assets ratio has evolved across 16 annual periods from 2010 to 2025. As of February 2026, the ratio stands at 92.2%, reflecting working capital of Skr156.52 Million against net assets of Skr169.79 Million SEK. Check Diamyd Medical AB (publ) tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Diamyd Medical AB (publ) (2010–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Diamyd Medical AB (publ) from 2010 to 2025, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Diamyd Medical AB (publ) worth.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 94.6% | Skr264.92 Million | Skr280.00 Million | Skr292.40 Million | Skr27.48 Million | ▲ +13.0 pp |
| 2024 | 81.6% | Skr119.12 Million | Skr145.92 Million | Skr159.14 Million | Skr40.02 Million | ▲ +10.2 pp |
| 2023 | 71.4% | Skr120.95 Million | Skr169.40 Million | Skr140.81 Million | Skr19.85 Million | ▲ +0.7 pp |
| 2022 | 70.7% | Skr151.64 Million | Skr214.38 Million | Skr173.01 Million | Skr21.37 Million | ▼ -9.4 pp |
| 2021 | 80.1% | Skr151.57 Million | Skr189.26 Million | Skr162.97 Million | Skr11.40 Million | ▲ +3.0 pp |
| 2020 | 77.1% | Skr55.90 Million | Skr72.49 Million | Skr72.39 Million | Skr16.50 Million | ▼ -4.5 pp |
| 2019 | 81.6% | Skr51.23 Million | Skr62.78 Million | Skr61.88 Million | Skr10.64 Million | ▼ -4.0 pp |
| 2018 | 85.6% | Skr36.83 Million | Skr43.01 Million | Skr47.19 Million | Skr10.36 Million | ▼ -8.6 pp |
| 2017 | 94.3% | Skr81.68 Million | Skr86.67 Million | Skr91.07 Million | Skr9.39 Million | ▼ -0.2 pp |
| 2016 | 94.5% | Skr27.65 Million | Skr29.26 Million | Skr32.95 Million | Skr5.30 Million | ▲ +33.3 pp |
| 2015 | 61.2% | Skr24.19 Million | Skr39.52 Million | Skr30.50 Million | Skr6.32 Million | ▼ -9.4 pp |
| 2014 | 70.6% | Skr31.20 Million | Skr44.16 Million | Skr37.21 Million | Skr6.02 Million | ▼ -29.5 pp |
| 2013 | 100.1% | Skr60.36 Million | Skr60.29 Million | Skr67.09 Million | Skr6.73 Million | ▲ +7.7 pp |
| 2012 | 92.5% | Skr378.67 Million | Skr409.58 Million | Skr390.05 Million | Skr11.38 Million | ▲ +2.9 pp |
| 2011 | 89.6% | Skr412.88 Million | Skr460.97 Million | Skr471.51 Million | Skr58.63 Million | ▲ +4.9 pp |
| 2010 | 84.7% | Skr266.62 Million | Skr314.78 Million | Skr521.03 Million | Skr254.41 Million | — |